PITTSBURGH, PA -- (Marketwired) -- 12/05/13 -- Diagnostic medical device manufacturer Neuro Kinetics Inc. (NKI) (www.neuro-kinetics.com) said today that industry veteran Michael Saporito has been appointed as its chief financial officer.
The company also said that Robert Kampmeinert has been elected to its board of directors.
NKI CEO and President Howison Schroeder said both bring professional experience that will help accelerate the company's growth strategy.
"Mike Saporito has served as an executive at a number of privately held and public companies, large and small, including in the medical device industry. That diversity of experience will be a great resource for us as we move forward," Schroeder said. "Mike knows how to position a growing company for success."
Saporito's most recent post was as vice president at the LifeVest division of Zoll Medical. He helped lead the turnaround of LifeVest and its subsequent acquisition by Zoll.
Other previous positions include with start-up TrueCommerce and with Cisco Systems and Perot Systems. Saporito holds a degree in finance from West Virginia University.
Robert Kampmeinert retired in 2010 as chairman of Janney Montgomery Scott LLC, a major investment and investment banking firm headquartered in Philadelphia. From 1985 to 2005 he was chairman and CEO of Parker/Hunter Incorporated, a regional investment firm headquartered in Pittsburgh. Parker/Hunter merged with Janney in 2005. Kampmeinert has served and currently serves on several boards of public and private companies as well as non-profit institutions. He graduated with a B.S. in economics from Lehigh University and an MBA from Harvard Business School.
"We are honored that Bob Kampmeinert has joined our board," said Schroeder. "His expertise in a wide range of operational and financial management arenas will be a significant asset for us as we continue expanding clinical uses of our diagnostic equipment.
"This is an exciting time for our company, and now all the more so because Michael Saporito and Bob Kampmeinert are on the team," Schroeder said.
Neuro Kinetics, Inc. (NKI) is the world leader in eye-tracking technology and non-invasive neuro-otologic diagnostic testing. Central to its product mix and technological advances is the premise that the eye is the portal to the brain. Research has shown the detection of abnormal eye reflexes can indicate the presence of more than 200 diseases and medical conditions.
NKI supplies comprehensive neuro-otologic diagnostic tools to audiologists, ENT's, neuro-otologists, neuro-ophthalmologists and neurologists around the globe. The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services.